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Aim. To evaluate capsule endoscopy in terms of incomplete examinations and capsule retentions and to ﬁnd risk factors for these
events.MaterialandMethods.Thisretrospectiveandconsecutivestudyincludesdatafrom2300capsuleenteroscopyexaminations,
performed at four diﬀerent hospitals in Stockholm, Sweden from 2003 to 2009. Results. The frequency of incomplete examinations
was 20%. Older age, male gender, suspected, and known Crohn’s disease were risk factors for an incomplete examination. The
PillCam capsule had the highest rate of completed examinations. Capsule retention occurred in 1.3% (n = 31). Risk factors for
capsule retention were known Crohn’s disease and suspected tumor. Complications of capsule retention were acute obstructive
symptoms in six patients and one death related to complications after acute surgical capsule retrieval. Conclusion:C a p s u l e
endoscopy is considered a safe procedure, although obstructive symptoms and serious complications due to capsule retention
can be found in a large series of patients.
1.Introduction
Capsule endoscopy (CE) has facilitated and improved vis-
ualization of the smallbowel mucosa.Since its ﬁrstintroduc-
tion by Iddan et al. [1], the method has been routinely
used primarily in cases of obscure gastrointestinal bleeding
(OGIB) and in the evaluation of patients with known or
suspected Crohn’s disease (CD). Several studies have shown
thesuperiorityofdetectingsmallbowellesionswithCEcom-
pared to other diagnostic modalities with these indications
[2–6].
Toperformahighqualityexaminationandmaximizethe
diagnostic yield, theentire smallbowel needs to bevisualized
[7, 8]. Only an average of 83.5% of the examinations are
completed, with completion deﬁned as the capsule reaching
the caecum during the recording time [9]. This indicates a
limitation of the method since the distal part of the intestine
remains unexamined in some patients. Prokinetic drugs,
as well as purgatives, have been evaluated to improve the
completion rate but were shown to be ineﬀective [8, 10,
11]. There is currently no validated scale to evaluate bowel
cleanliness and no common guideline for bowel preparation
although poor views, especially in the distal part of the small
intestine, are considered a limitation [8, 10, 12, 13].
Capsule retention is the most feared complication of CE
[14] and is deﬁned as the presence of the capsule endoscope
in the digestive tract for a minimum of 2 weeks or more, or
when the capsule is retained indeﬁnitely in the small bowel
unless a targeted medical or surgical intervention is initiated.
Several studies have recently addressed capsule retention [9,
12, 15–17]. It is important to diﬀerentiate capsule retention
from incomplete examination, meaning that the capsule did
not reach the caecum during the recording time and delayed
transit, which is when the capsule is harboured in the same
part of the intestine for more than 2 hours [14], which might
be diﬃcult to identify in the small intestine. In the general2 Gastroenterology Research and Practice
population, the risk of capsule retention ranges from 1.4% to
2.5% [15, 16] and in patients with known CD a 13% risk has
been observed [17]. The most common reasons for capsule
retention are CD, obstructive tumor, and diaphragm disease
due to the side eﬀects of nonsteroid anti-inﬂammatory drugs
[9,15, 17,18]. Patients with OGIB are considered to be at the
lowest risk for capsule retention, and patients with a history
of obstructive symptoms are at the highest risk [14, 17].
Radiological methods, though improving over time, cannot
rule out the possibility of an intestinal stricture [19, 20]. A
method for detecting strictures by means of a soluble test
capsule has been developed (Agile Patency Capsule, Given
Imaging), and results so far have been promising [21]. CE
is considered a safe procedure, and, even in cases of capsule
retentions, obstructive symptoms due to impaction of the
capsuleorseriousadverseadventsfollowingsurgicalremoval
of the capsule are rare [7, 9, 13, 15].
This retrospective study included all patients undergoing
CE in Stockholm and Gotland Counties in Sweden between
2003 and 2009. The primary aim of the study was to evaluate
CE in terms of incomplete examinations and capsule reten-
tions in a large unselected population by including all CE
per zformed during these years. Our secondary aim was to
characterize the clinical outcomes of patients with capsule
retention.
2.MaterialandMethods
This study comprised 2300 small-bowel CE examinations
performed at 4 diﬀerent hospitals in Stockholm, Sweden
between June 2003 and December 2009. All CE studies
performed in Stockholm County, consisting of 2 million in-
habitants, during this time period were included.
The introduction of CE started at Stockholm S¨ oder Hos-
pital (Center 1) in June 2003. At this hospital, the Given
PillCam SB capsule endoscope (Given Imaging, Yokneam,
Israel) was used, and 1473 (77%) of the investigations were
carried out using this system. Karolinska University Hospital
(Center 2) started CE examinations 4 years later (June 2007)
and used the Olympus capsule endoscope (Olympus, Tokyo,
Japan). At this hospital, 490 (23%) of the examinations
were performed. Ersta Hospital (Center 3) also started in
June 2007, and at this hospital 302 CE examinations were
performed using the Given PillCam SB system. Danderyd
Hospital (Center 4) started CE examinations in August
2009, using the MiroCam capsule device (Intromedic, Seoul,
Korea) and performed 35 examinations by the end of 2009.
All centers contributed data on the total number of
CE examinations that were performed as well as data on
age, gender, indications, view, and ﬁndings in patients with
incomplete examinations. Centers 1 and2 (n = 1963, 85% of
the all CE examinations) also contributed these facts for all
patients receiving CE during the study period.
Indications for CE were OGIB, known or suspected CD,
suspected tumor and others. Tumor, was suspected when a
previous radiological examination, mainly computer tomog-
raphy, had raised the suspicion or in cases with a clinical
suggestion of malignancy, such as weight loss, unexplained
fever, laboratory ﬁndings, and symptoms pointing towards
malignancy. “Other” indication included diarrhea, coeliac
disease, and abdominal pain.
All medical charts and records of the patients referred for
CE were reviewed by a gastroenterologist. If the indication
for the CE was bleeding, all patients must have had at least
one negative upper endoscopy and one normal colonoscopy
at a concurrent time. In cases of suspected or known
CD, contraindications such as symptoms of small bowel
obstruction or known strictures were ruled out. Radiological
exclusion of strictures by means of enteroclysis, MRI, or CT
was not required before CE.
Patientpreparationincludedaliquiddietthedaypriorto
the CE examination and nothing by mouth from midnight.
Afterswallowingthecapsule,thepatientswereallowedliquid
food after 2h and an ordinary diet after 4h. No laxative
was given. In a few patients in which slow gastric transit
was highly likely (diabetics, inward-patients, patients on opi-
oids, and patients with a previous CE where the capsule re-
mained in the stomach during the whole recording time)
a real time viewer was used 1h after ingesting the capsule,
and in the case of visualized gastric mucosa, gastroscopy was
performed, and the capsule was manually placed in the duo-
denum using a Roth-net.
In those patients where the capsule did not reach the
cecum and excretion was not witnessed, an abdominal X-
ray was obtained about 2 weeks later. Especially during the
ﬁrst years of use, this routine was not always followed, and
in those cases patients were classiﬁed as “lost” in this study.
If the patient witnessed spontaneous passage, the X-ray was
cancelled.
Capsule retention was deﬁned as the capsule visualized
inside the small intestine by radiological examinations two
weeks after CE or found during abdominal surgery in
an obstructed part of the small intestine. Patients with a
conﬁrmed, indeﬁnitely retained capsule were mostly referred
for surgery and in all cases were closely followed up. Before
surgery was initiated, a new radiological control of the
retained capsule was usually done, and in a few cases the
capsule had passed spontaneously, even after several months
of retention, and these patients were excluded from the
capsuleretentiongroup.Theremainingpatientswithcapsule
retention are presented in detail in this study. The CE studies
were read by gastroenterologists and, to keep the method in
fewer hands, no more than two gastroenterologists at each
center were involved.
To identify risk factors for capsule retention and incom-
plete CE examination, a multivariable analysis using logistic
regression was made. In this analysis, only patients from
Centers 1 and 2 were included since the data of age, gender,
and indications for CE were not known for patients with
complete CEs at Centers 3 and 4. In this analysis, we
also distinguished patients with previously known CD from
patients with a suspicion of CD.
To ﬁnd out if there were any diﬀerences between the
two most used capsule systems, Olympus and PillCam, we
compared the completeness of examinations between Center
1 (using only PillCam) and Center 2 (using only Olympus
capsule). Only patients with OGIB as an indication for CEGastroenterology Research and Practice 3
were compared in order to avoid interference of diﬀerent
management between the two centers involved. Also OGIB
is the indication least likely to give rise to capsule retention
[14]. At both centers, CE is the next examination done after
negative gastroscopy and colonoscopy of good quality in the
case of OGIB. Both centers used the same preparation and
scheme, as described above, during the examination day.
Pearson’s chi-square tests were used for calculating the signi-
ﬁcance.
Statistics were calculated using PASW Statistics 18 (IBM
Corporation, Somers, USA). The level of signiﬁcance was set
at 0.05, two sided, for all analyses.
This study was approved by the Regional Ethical Review
Boards in Stockholm (no. 2010/1819-31/3).
3. Results
A total of 2300 CE examinations were performed in Stock-
holm County between June 2003 and December 2009. CE
failed because of technical failures in 6 patients (all PillCam
SB), and these patients were excluded. 5 patients were unable
to swallow the capsule and declined endoscopic placement
of the capsule into the stomach. The overall indications for
CE (known for all patients from Centers 1 and 2, n = 1957,
85% of all CE examinations) were as follows: bleeding source
(n = 1034, 53%), suspected CD (n = 577, 29%), known
CD (n = 152, 8%), tumor (n = 118, 6%), and others (n =
78, 4%). The mean age was 51 years (range 2–99 years)
and 57% were female (n = 1117). The diagnostic yield was
55%.
3.1.IncompleteExaminations. Atotalof463(20%)examina-
tions were incomplete, meaning that there was failure of the
capsule to reach the caecum during the recording time (8–
11h depending on the capsule system). The mean age of
patients with incomplete examinations was 53 years (range
6–99 years), and 53% were female. Indications for CE were
OGIB (n = 208, 45%), known or suspected CD (n =
191, 41 %), tumor (n = 46, 10%), and others (n = 18,
4%). The most common ﬁnding was CD (n = 104, 22%
of examinations). Other ﬁndings were slow gastric transit
where the capsule remained in the stomach for the whole
recording time (n = 63, 14%), vascular disease (n = 37,
8%), tumor (n = 20, 4%), and others (n = 74, 17%).
164 (35%) examinations were normal. 77 (17%) patients
were lost for followup after incomplete CEs. The diagnostic
yield was 51%.
3.2. Risk Factors for Incomplete Examination. The risk of in-
complete examination (analysed for patients from Centers 1
and 2) was higher for male patients with an odds ratio of
1.34 (1.08–1.67, P = 0.009) and increased with age with
an odds ratio of 1.02 per year (1.01–1.02, P<0.001). The
odds ratio for an incomplete examination was signiﬁcantly
elevated for patients with both suspected and known CD,
suspected tumor, and other indication compared to OGIB
(Table 1).
Table 1: Odds ratio of obtaining an incomplete CE for diﬀerent
indications (adjusted for age and gender).
Diagnose Odds ratio Signiﬁcance 95% C.I
OGIB 1 — —
Suspected CD 1.45 P = 0.018 1.06–1.96
Known CD 3.74 P<0.001 2.52–5.58
Tumor 1.81 P = 0.006 1.19–2.76
Other 2.051 NS 1.15–3.66
3.3. Capsule Retentions. Capsule retention was found in 31
(1.3%) patients (Table 2). The mean age was 51 years, and
47% were female. Indications for CE in this group were
OGIB (n = 10, 32%), known or suspected CD (n = 16,
52%), tumor (n = 4, 13%), and others (n = 1, 3%). Findings
were CD (n = 15, 48%), tumor (n = 6, 19%), stricture (non-
CD; n = 4, 13%), erosions (n = 2, 6%), on-going bleed-
ing (n = 1, 3%), and normal ﬁndings (n = 3, 10%). In
27 patients, the capsule was removed surgically and, in one
patient, by means of double-balloon enteroscopy. Two of
the patients still have the capsule retained after 2 years of
expectation. One patient with CD and a stricture had the
capsule retained for 2.5 years, and thereafter spontaneous
passage occurred. During this time, the patient was treated
with TNF-alfa-antibodies.
Severe obstructive post-CE symptoms were reported
from seven patients. Symptoms of obstruction appeared 0–
4 weeks after the CE-examination. In six of the patients,
intestinal obstruction with the capsule remaining in the
aﬀected area was conﬁrmed by radiology, and in the seventh
patient the capsule was found proximal to the obstruction.
T h es u r g i c a lp r o c e d u r e sw e r ep e r f o r m e da sa c u t eo rs e m i a -
cute, 1-2 days after the radiology examination in six patients.
One patient had a radiological conﬁrmed capsule retention,
and in this case surgery was performed acute without a
new radiology conﬁrmation when the obstructive symptoms
appeared. In all seven patients obstructive intestinal disease
was found during surgery, but in three of the patients no
capsule was found. The clinical evaluation was that CE had
contributedtoonsetoftheacuteobstructivesymptomsinsix
of the seven patients.
Postoperative complications were reported in 3 of the
27 operated patients and two of them died a few days after
surgery. The ﬁrst patient had widespread malignant disease
and died of multiorgan failure at the intensive care unit. The
secondpatientwasa53-year-oldmaninwhomacutesurgery
wasperformedduetoobstructivesymptoms.Inthiscase,CD
and strictures were found, and a small bowel resection was
performed. He seemed to recover well and was released from
the hospital ﬁve days later. Six days after surgery he suddenly
collapsed at home and was dead on arrival to the hospital.
Postmortem showed rupture of the anastomosis.
3.4. Risk Factors for Capsule Retention. The risk of capsule
retention (analysed for patients from Centers 1 and 2) was
not correlated to gender (P = 0.19) or age (P = 0.14). The
highestriskwasfoundinpatientswithpreviouslyknownCD4 Gastroenterology Research and Practice
Table 2: Patients with capsule retention.
Nr Age/gender∗ Indication
for CE
Findings in
CE
Acute
obstruction Findings in surgery Outcome after one
year
1 53/M OGIB CD No CD and stricture Well∗∗
2 28/M OGIB Ongoing
bleeding Yes
Lymphoma, capsule
found but not
responsible for
obstruction
Died two months
later (rupture of
anastomosis)
3 77/F OGIB Normal No Lymphoma
Died two month
later (widespread
disease)
4 81/F OGIB Stricture No Stricture (radiation) Regress of bleeding
5 75/M Tumor Normal No Adenocarcinoma Well
6 59/M OGIB Normal No Stricture of
anastomosis Well
7 40/M Other Tumor No Metastasis of
teratoma Lost for followup
8 34/M OGIB Tumor No Adenocarcinoma Dead (wide-spread
disease)
9 43/F CD? CD Yes CD, stricture Well
10 14/F Known CD CD and
stricture No CD, stricture Well
11 64/F OGIB Stricture No Stricture (radiation) Well
12 78/F Tumor Intestinal
dilatation Yes
Adenocarcinoma—
widespread, capsule
found in the
stomach
Died 4 days
post.op
(Multiorgan-
failure)
13 73/F Tumor Erosions No Stricture Lost for followup
14 18/M Known CD CD, stricture No CD, stricture Well
15 53/M Known CD CD, stricture Yes CD, stricture,
capsule not found
Died 6 days
post.op (rupture of
anastomosis)
16 32/M Known CD CD Yes CD, stricture Well
17 23/M Known CD CD, stricture No
Declined retrieval,
capsule retained 2
years then passed
out
Well
18 58/F Known CD CD, stricture Yes CD, stricture Well
19 79/F OGIB Stricture No
Stricture
(radiation), capsule
not found
Well
20 16/M Known CD CD No
Declined retrieval
before, op now
planned
Well (2,5 years)
21 48/M CD? CD No No, declined
retrieval Well (2 years)
22 64/M OGIB CD, stricture No CD, stricture Abdominal pain
23 67/F Known CD CD Yes CD, ileus
(adhesions) Well
24 49/F CD? Stricture No Stricture (radiation) Well
25 53/M OGIB Tumor No
Capsule retrieved by
means of DBE∗∗∗,
PAD =
adenocarcinoma
Well
26 33/F Known CD CD, stricture No CD, stricture Well
27 67/M Known CD CD, tumor No Adenocarcinoma Well
28 38/F Known CD CD No CD, stricture WellGastroenterology Research and Practice 5
Table 2: Continued.
Nr Age/gender∗ Indication
for CE
Findings in
CE
Acute
obstruction Findings in surgery Outcome after one
year
29 63/F CD? Erosions Yes
Stricture
(radiation),
perforation, capsule
not found
Well
30 48/M Known CD Erosions Yes CD, stricture,
capsule not found Well
31 50/M Tumor Tumor No Metastasis of
teratoma Well
∗M: Male, F: Female, ∗∗Well: no clinical symptoms such as bleeding, abdominal pain, or diarrhea, ∗∗∗Double balloon enteroscopy.
Table 3: Odds ratio of capsule retention of the capsule for diﬀerent
indications (adjusted for age and gender).
Diagnose Odds ratio Signiﬁcance 95% C.I
OGIB 1 — —
Supected CD 0.76 NS 0.18–3.08
Known CD 9.39 P<0.001 3.32–26.54
Tumor 3.88 P = 0.026 1.18–12.81
Other 3.99 NS 0.80–19.87
with an odds ratio of 9.39 (3.32–26.54, P<0.001) compared
with OGIB. Suspected tumor as the indication for CE was
also connected to a higher risk of capsule retention (Table 3).
3.5. Diﬀerences in Completeness between the Capsule Systems.
At Center 1, using the PillCam capsule, 695 of 842 examina-
tions due to OGIB were completed (82.5%). The mean age
was 60 years. At Center 2, using the Olympus capsule, 144
of 195 examinations due to OGIB were completed (73.9%).
T h em e a na g ew a s5 9y e a r s .T h ed i ﬀerence in completeness
of examination was statistically signiﬁcant (P = 0.005).
4. Discussion
Capsule endoscopy has been a routine, ﬁrst-line method
to evaluate the small bowel since it was initiated about 10
years ago. It has been validated in a large number of studies,
and, even though other methods for reaching the distant
part of the small intestine have been developed, it is still
widely used, probably because it has high sensitivity [22]
and user-friendly management. We believe there is a need to
continuously validate a method, especially when it achieves
widespread use. This large study evaluating all CE investiga-
tions over a six-year period in Stockholm County shows a
l o wr a t eo fr e t e n t i o n sa ﬀecting, in particular, patients with
known CD or suspected tumor. The overall prognosis and
outcome of the patients with capsule retention due to a
benign disease were good although one fatal case occurred
as a result of surgical capsule retrieval.
The total number of CEs and complete data on patients
with an incomplete CE were available from all hospitals,
but complete data on all patients undergoing CE were only
possible to obtain from Centers 1 and 2 (which performed
85% of all the CE examinations). It is a weakness of this
study that these data from Centers 3 and 4 are missing when
calculating the odds ratios of incomplete examination and
capsule retention. However, it is unlikely that the missing
data would have had a great impact due to the relatively low
number of CEs performed at these centers.
Slow gastric transit with the capsule harboured in the
stomach for the entire recording time was found in 14% of
incomplete examination cases and was obviously a factor
lowering the success rate. Use of prokinetics has not been
shown to improve gastric transit times [8, 10]. A more
frequent use of a real time viewer with manual placement of
the capsule in the duodenum, in the case of gastric retention,
may improve the possibility of complete transit.
Male gender and older age were identiﬁed as risk factors
for incomplete examination, but these factors were not of
statistical signiﬁcance when considering capsule retention.
Olderagecomeswithhigherriskofconcomitantdiseaseslike
diabetes, and this could be an explanation for age as a risk
factor.
The two most common capsule systems were compared
in terms of completed examinations. The PillCam capsule
was superior to the Olympus capsule in this aspect. We could
not ﬁnd any obvious reason for this diﬀerence between the
two capsule systems.
Follow up of patients with capsule retention showed
overall good recovery in patients with nonmalignant disease.
In most patients, capsule endoscopy contributed to the
diagnosis, and patients were relieved from symptoms due to
tumors or strictures after surgery. However, one patient, a
53-year-old man with CD, died because of a rupture of the
anastomosis six days after surgery. This is probably a rare
case, since CE has been proven safe in numerous studies
[7, 9, 13, 19] but reﬂects the risk of serious adverse events
in a large series of patients.
Acute or semiacute surgery was performed in seven
cases due to obstructive symptoms in patients with capsule
retention. Rather surprisingly, the capsule was not found
during surgery in three of these patients. One theory is
that the capsule caused symptoms while passing through
the stricture. The capsule might also have returned to a
more proximal position in the small intestine. The clinical
conclusion was that CE had contributed to onset of acute6 Gastroenterology Research and Practice
obstructive symptoms in at least six of the seven patients
although the underlying disease of course was the main
reason for intestinal obstruction. Obstructive symptoms due
toimpactionofthecapsulewerereportedinotherstudiesbut
at a lower frequency [13, 15, 23]. This study indicates that it
might be more common than previously thought.
Inthisstudy,knownCDwastheindicationofhighestrisk
for capsule retention which is in accordance with previous
literature [9, 17]. Suspected tumor was also shown to be a
risk factor. In a large multicenter study, ﬁndings of tumors
were shown to be associated with capsule retention in
9.8% [18]. In the case of a stricturing tumor, the patient
usually needs surgery anyway, and the capsule then can be
removed. A stricture in a patient with CD could have been
asymptomatic and still prevented the passage of the capsule,
[17] and thus, there is a risk of unnecessary surgery if the
capsule has to be removed. On the other hand, CE can be
a way of ﬁnding a signiﬁcant stricture that needs surgical
intervention [24]. The use of a patency capsule before CE
is a method to lower the risk of capsule retention [21]b u t
also excludes some patients from being diagnosed by CE.
Advantages and disadvantages of CE examination should be
consideredcarefully,inparticular,whenhighriskpatientsare
involved.
The most common means of retrieval of the capsule
in this study was surgical; however, in the future, device-
assisted enteroscopy will probably be used increasingly as an
alternativetosurgery[23].Ourresultsalsosupportthisman-
agement.
5. Conclusion
Incomplete examination was found in 20% of all CE
examinations and is a major limitation of the method. Cap-
sule retention was found in 1.3% of the CE examinations.
Older age, male gender, known and suspected CD, and sus-
pected tumor are connected to a risk of incomplete CE ex-
amination.KnownCDandsuspectedtumorarealsoriskfac-
tors for capsule retention. CE has a low complication rate,
but it includes a small risk of obstructive symptoms and a
needforsurgicalinterventioninthecaseofcapsuleretention.
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